Casdin Capital
Jack McGuire, Research Associate, joined Casdin Capital in 2022 and focuses on targeted and next-generation therapeutics.
Prior to joining Casdin, Jack worked as a strategy consultant at Back Bay Life Science Advisors, helping small-to-mid sized biotech companies navigate complex business, scientific, and financial challenges. Previously, Jack conducted cell and developmental biology research at Vanderbilt Medical Center.
Jack graduated from Vanderbilt University with a Bachelor of Science degree in Biochemistry and Chemical Biology.
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.